YATHARTHNSE18 August 2023

Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Investor Presentation

Yatharth Hospital & Trauma Care Services Limited

August 18, 2023

The Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1 G Block, Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051

Dept. of Listing Operations BSE Limited, P J Towers, Dalal Street, Mumbai -400001, India

Symbol: YATHARTH

Scrip Code: 543950

Dear Sir/Ma’am,

Sub:-Investor's presentation- 01 &FY24 Results.

Please find enclosed Investor's Presentation for Q1 & FY24 Results pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

Kindly take the same in your records.

Thanking you,

Your faithfully, For Yatharth Hospital and Trauma Care Services Limited

Ritesh Mishra Company Secretary & Compliance Officer Enclosed: As above

m o c

a t

p s o h h t

r a h t a y

w w w

Q1 FY24 Earnings Presentation

August 17, 2023

Disclaimer

Certain matters discussed in this Presentation may contain statements regarding the company’s market

opportunity and business prospects that are individually and collectively forward-looking statements. Such

forward-looking statements doesn’t guarantee future performance and are subject to known and unknown

risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but

are not limited to, the performance of the economy,

industry, competition, the company’s ability to

successfully implement its strategy, technological

implementation, changes and advancements, the

company’s market preferences and its exposure to market risks, as well as other risks. The company’s actual

results, levels of activity, performance or achievements could differ materially and adversely from results

expressed in or implied by this presentation. The company assumes no obligation to update any forward-

looking information contained in this presentation. Any forward-looking statements and projections made

by third parties included in this presentation are not adopted by the company and the company is not

responsible for such third-party statements and projections. You are cautioned not to place undue reliance

on these forward-looking statements, which are based on the current view of the management of the

Company on future events.

Q1 FY24 Performance Highlights

Q1FY24 Financial Highlights

▪ Revenue growth of 39% YoY, across all

specialties and super-specialties

▪ EBITDA grows by 61% YoY. EBITDA Margin

expanded by 368bps YoY to 26.8%, driven

by operating leverage

▪ PAT grows by 73% YoY. PAT Margin

expanded by 242 bps to 12.3%

respectively

Rs. 1,545 mn +39% YoY +7% QoQ

Revenue

Rs. 414 mn +61% YoY +8% QoQ

26.8% Margin +368bps YoY +5bps QoQ

Rs. 190 mn +73% YoY +10% QoQ

12.3% Margin +242bps YoY +28bps QoQ

EBITDA

PAT

Financial Highlights

Revenue (Rs mn)

EBITDA (Rs mn)

PAT (Rs mn)

+39%

+7%

1,438

1,545

1,111

23.1%

257

50 0

49 5

49 0

48 5

48 0

475

470

46 5

46 0

45 5

45 0

44 5

44 0

435

430

425

420

415

410

40 5

40 0

395

390

385

380

375

370

365

360

355

350

345

340

335

330

325

320

315

310

305

300

295

290

285

280

275

270

265

260

255

250

245

240

235

230

225

220

215

210

205

200

195

190

185

180

175

170

165

160

155

150

145

140

135

130

125

120

115

110

105

100

26.8%

385

414

30%

25%

20%

15%

10%

300

295

290

285

280

275

270

265

260

255

250

245

240

235

230

225

220

215

210

205

200

195

190

185

180

175

170

165

160

155

150

145

140

135

130

125

120

115

110

105

100

9.9%

110

12.0%

12.3%

173

190

18%

17%

16%

15%

14%

13%

12%

11%

10%

Q1FY23

Q4FY23

Q1FY24

Q1FY23

Q4FY23

Q1FY24

Q1FY23

Q4FY23

Q1FY24

Operational Highlights

❑ Occupancy was 51% in Q1FY24, vs 40% in Q1FY23 and 49% in Q4FY23

Noida hospital reported high occupancy levels of 92%

❑ ARPOB for Q1FY24 was Rs. 28,140, vs Rs. 26,457 in Q1FY23 and Rs. 27,706 in Q4FY23

Noida extension hospital reported highest ARPOB of Rs. 33,926

❑ Inpatient volume improved by 14% YoY

❑ OPD consultation tariff for 3 hospitals in Delhi NCR has been revised up by approx. 12%

❑ Nephrology & urology (renal sciences) registered a growth of 56% YoY, while cardiology grew 35% YoY

❑ Oncology revenues almost tripled year-on-year during the quarter

❑ Completed 50 successful kidney transplants since inception of the programme

Operational KPIs

Revenue Mix (Rs mn)

Patient Volume (in ‘000s)

Inpatient Revenue

Outpatient Revenue

4,519

Inpatient Volume

Outpatient Volume

330

1,267

1,359

950

3,464

223

160

171

186

546

684

Q1FY23

Q4FY23

Q1FY24

FY22

FY23

Q1FY23

Q4FY23

Q1FY24

FY22

FY23

ARPOB (Rs)

28,140

27,706

26,538

ALOS (days)

4.5

4.6

5.2

4.3

26,457

24,000

4.0

Q1FY23

Q4FY23

Q1FY24

FY22

FY23

Q1FY23

Q4FY23

Q1FY24

FY22

FY23

ARPOB – Average Revenue per Occupied Bed; ALOS – Average Length of Stay

Operational KPIs

Chart Title Hospital-wise Revenue (Rs mn)

1,111

451

381

269

Q1FY23

528

442

405

559

465

443

Q4FY23

Q1FY24

Greater Noida

Noida

Noida Extension

Jhansi-Orchha

Consolidated

1,438

1,545

79%

56%

40%

26%

Q1FY23

Chart Title Hospital-wise Bed Occupancy

91%

63%

49%

36%

14%

92%

66%

51%

37%

17%

Q4FY23

Q1FY24

Greater Noida

Noida

Noida Extension

Jhansi-Orchha

Consolidated

Specialty Mix

Q1 FY23

Q1 FY24

Organ Transplant , 0%

Oncology, 1%

Pulmonology, 4%

Gastroenterology, 2%

Others*

Gynecology, 4%

Pediatrics, 4%

Cardiology 10%

Medicine

33%

Total Revenue Rs. 1,111 mn

General surgery

10%

Orthopedics & spine &

rheumatology, 7%

Nephrology & urology

Neurosciences

10%

*Others include:

Organ Transplant , 1%

Oncology, 3%

Pulmonology, 5%

Others*

Gastroenterology, 3%

Gynecology, 4%

Pediatrics, 4%

Cardiology

10%

General surgery, 8%

Medicine

33%

Total Revenue Rs. 1,545 mn

Orthopedics & spine &

rheumatology, 6%

Neurosciences

Nephrology &

urology 10%

Clinical Achievements

Profit & Loss Summary

Particulars (Rs Mn)

Q1FY24

Q4FY23

Change QoQ

Q1FY23

Change YoY

Revenue from Operations

1,545

1,438

281

268

582

414

257

250

545

385

1,111

213

195

446

257

39%

32%

37%

31%

61%

FY23

FY22

5,203

4,009

929

919

2,017

1,338

813

805

1,283

1,108

Change YoY

30%

14%

57%

21%

26.8%

5 bps

23.1%

368 bps

25.7%

27.6%

(193 bps)

294

103

190

249

173

(17%)

12%

18%

36%

10%

157

110

13%

32%

29%

87%

120%

73%

275

214

849

219

633

279

215

615

189

428

(1%)

38%

16%

48%

Medical Consumables & Pharmacy items

Employee Expenses

Other Expenses

EBITDA

EBITDA Margin %

Depreciation and amortisation

Financial Cost

Other Income

Profit Before Tax (PBT)

Tax

Profit After Tax (PAT)

PAT Margin %

12.3%

12.0%

28 bps

9.9%

242 bps

12.2%

10.7%

149 bps

About The Company

At a Glance Leading super specialty hospital in Delhi-NCR

Among top 10 largest private hospitals of Delhi NCR region in terms of number of beds

One-stop destination for patient needs providing all levels of healthcare services from primary to tertiary

2019 Noida Extension

2013 Noida

2010 Greater Noida

Hospitals

Center of Excellence

1,405

Operational Beds FY21-23 CAGR +28%

Rs. 28,140

ARPOB FY21-23 CAGR +12%

4.62 days

ALOS FY21-23 CAGR (7%)

2022 Jhansi-Orchha

Revenue Rs 5,203mn FY21-23 CAGR 51%

EBITDA Rs 1,338mn 25.7% Margin FY21-23 CAGR 41%

Net Profit Rs 658mn 12.6% Margin FY21-23 CAGR 90.3%

ROCE 26.1%

Our Journey Growing presence across regions and services

2008

Incorporation of company and commencement of operations

2013

2019

2023

Established our second 250 bedded hospital, in Noida

Commencement of our third hospital, Noida Extension hospital, in May 2019, pursuant to the acquisition of subsidiary AKS in 2016

Listing on NSE & BSE

Established our first hospital in Greater Noida

Expansion of our first hospital, Greater Noida hospital, to 400 beds

Acquisition of 4th hospital - Jhansi Orchha hospital adding 305 beds, pursuant to acquisition of subsidiary, Ramraja

2010

2018

2022

Continued expansion into specialized services - Neurology, Cardiology, Nephrology, Orthopedics and Oncology

Plan to introduce radiation therapy and liver transplant operations

Diversified revenue mix across hospitals (FY23)

Jhansi

Orchha 3%

Noida

Extension 26%

Greater

Noida 38%

Noida

33%

Hospitals

➢ Built on foundation of talent, trust, technology, service and infrastructure

➢ Complying with international quality standards

➢ NABH accredited hospitals

Greater Noida

Noida

Noida Extension

Jhansi - Orchha

Year of Operation

Beds Capacity

Occupancy Rate

2010

400

62%

2013

250

88%

2019

450

31%

2022

305

ARPOB (₹)

26,539

24,949

30,475

17,692

ALOS (days)

4.4

5.8

3.1

In-Patient Volume

17,255

11,957

14,186

3.8

1,960

Outpatient Volume

1,37,937

72,906

102,278

16,639

Note: FY23 figures

Greater Noida Hospital Overview

Revenue from Operations (Rs mn)

1,994

Provides a wide spectrum of super specialty services in the field of cardiology,

cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology,

1,702

oncology, gastroenterology etc.

811

Strategy to develop this hospital as the Centre of Excellence for Human Organ

Transplant and as a major center for medical tourism

Recently acquired land parcel of 1,885 sq mt adjacent to hospital with the intention

FY21

FY22

FY23

ARPOB (Rs)

In-Patient Volume

to expand the bed capacity

9 3 5 6 2

1 2 6 3 2

4 5 7 , 1 2

5 5 2 , 7 1

0 2 0 5 2 1 2 3 9

FY21

FY22

FY23

FY21

FY22

FY23

ALOS (days)

Out-Patient Volume

4.8

4.4

4.0

7 3 9 , 7 3 1

0 0 3 6 1 1

0 2 5 , 2 8

FY21

FY22

FY23

FY21

FY22

FY23

400 Bed Capacity

112 ICU

62% Occupancy

Note: FY23 figures

Noida Hospital Overview

Revenue from Operations (Rs mn)

Provides services across 30 specialties,

including cardiac sciences,

1,721

orthopedics, nephrology, urology, neurosciences, gastroenterology, etc.

1,283

681

Strategy to improve ALOS and improve the combination of super specialties,

for better ARPOB

FY21

FY22

FY23

ARPOB (Rs)

In-Patient Volume

9 4 9 4 7 2 1 6 , 2 2

6 3 4 , 1 2

7 5 9 , 1 1

6 1 3 9

6 1 8 , 7

FY21

FY22

FY23

FY21

FY22

FY23

ALOS (days)

Out-Patient Volume

6.1

5.8

4.1

6 0 9 , 2 7

9 9 7 , 6 5

1 7 6 4 4

FY21

FY22

FY23

FY21

FY22

FY23

250 Bed Capacity

81 ICU

88% Occupancy

Note: FY23 figures

Noida Extension Hospital Overview

Revenue from Operations (Rs mn)

1,357

1,023

795

One of the largest hospital in the Noida Extension region, offering a mix of 11

modular and other operation theatres Plan to develop this hospital as a Centre of Excellence for oncology

treatment and robotic surgeries

Plan to start liver transplant operations, and have recently started bone

marrow and kidney transplant operations

Declared as highest bidder for an adjacent land, which will support future

FY21

FY22

FY23

bed capacity expansion

ARPOB (Rs)

In-Patient Volume

5 7 4 0 3

4 3 5 4 2

0 1 7 , 0 2

6 8 1 , 4 1

7 5 4 8 8 1 2 , 4

FY21

FY22

FY23

FY21

FY22

FY23

ALOS (days)

Out-Patient Volume

9.1

4.9

3.1

4 6 5 8

0 3 7 , 9 4

8 7 2 , 2 0 1

FY21

FY22

FY23

FY21

FY22

FY23

450 Bed Capacity

125 ICU

31% Occupancy

Note: FY23 figures

Jhansi – Orchha Hospital Overview

One of the largest hospital in Jhansi-Orchha-Gwalior region

Revenue from operations Rs. 131 mn

Acquired in FY22, aimed at further expanding into new geographies and

growing presence in the regional healthcare market

Hospital has infrastructure to operate all the major super specialties

ARPOB Rs. 17,692 mn

ALOS 3.8 days

In-Patient Volume 1,960

Out-Patient Volume 16,639

Commenced commercial operations in FY23 w.e.f April 10, 2022

Plan to introduce a fully functional oncology treatment unit in FY2025

305 Bed Capacity

76 ICU

8% Occupancy

Note: FY23 figures

Our Specialties (1/2) Expanding share of high value specialties

Diversified specialty services

2023

31%

10%

6% 5% 5% 4% 3% 9%

2022

50%

30 Specialties and Super specialties including 10 Centers of Excellence (COE)

Our COEs ➢ Centre of Medicine

➢ Centre of Cardiology

➢ Centre of Neurosciences

➢ Centre of General surgery

➢ Centre of Nephrology & Urology

2021

56%

➢ Centre of Pediatrics

➢ Centre of Gastroenterology

➢ Centre of Pulmonology

➢ Centre of Gynecology

➢ Centre of Orthopedics & Spine &

Rheumatology

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Medicine Cardiology General Surgery Pediatrics Gynecology Others

Neurosciences Nephology & Urology Orthopedics, Spine & Rehumatology Pulmonology Gastroenterology

Our Specialties (2/2) Expanding share of high value specialties

FY21-23 CAGR

) n m . s R ( e u n e v e R

13%

66%

77%

72%

82%

65%

79%

108%

131%

209%

53%

Revenue change - FY23 vs FY21

FY2021

FY2023

7 3 6 , 1

9 0 5

2 4 4

e n c d e M

s e c n e c s o r u e N

y g o o d r a C

y r e g r u S

a r e n e G

3 7 4

& y g o o h p e N

y g o o r U

5 9 2

y g o o t a m u h e R &

0 3 2

y g o o c e n y G

5 6 2

s c i r t a d e P

y g o o r e t n e o r t s a G

8 5 1

2 4 2

y g o o n o m u P

7 4 1

s r e h t O

e n p S

s c d e p o h t r

▪ Increase in share of higher value specialties such as Cardiology and Neurosciences, leading to higher ARPOB ▪ Organ transplant operations started in December 2022 and radiation and pet lines expected to be ready in few months ▪ Strengthening super-specialties by on-boarding new reputable and experienced doctors

Payer mix Balanced revenue split between payer categories

Self-payers

1,605

1,888

FY22

FY23

Insurers through TPA

1,227

1,381

FY22

FY23

Government Bodies

1,177

1,934

FY22

FY23

885

FY21

669

FY21

733

FY21

Figures in Rs mn

FY2023

Self-payers

and others

36%

Central, state

and local

government

bodies

under

government

scheme

37%

Insurers acting through

third party

administrators

27%

OUR STRENGTHS

Strengths

Among the leading super-specialty hospital in Delhi NCR with diverse specialty and payer mix

Regional advantage

Advanced and high-end medical equipment and technology

Experienced and professional management team

Team of highly qualified medical professionals

Track record of stable operating & financial performance

Leading hospital in Delhi NCR with diverse mix

Diversified revenue mix in terms of specialties, hospitals and customers allowing to grow

Specialty Profile

business and maintain a relatively de-risked business proportions

2 of Yatharth’s hospitals are amongst top 10 largest private hospitals in Delhi NCR in

terms of number of beds in FY2023

Hospital Mix

Payer Mix

Jhansi Orchha 3%

Noida

Extension 26%

Greater Noida 38%

Noida 33%

Note: FY23 figures

Self-payers

and others, 36%

Government,

37%

Insurers through TPA, 27%

26%

31%

10%

Medicine Cardiology Neurosciences Nephrology & urology General surgery Orthopaedics & spine & rheumatology Others

Regional Advantage

Integrating talent from well-established allied workforce

First mover advantage in building out network across Tier II/III cities

Stronger local connect with people

Promoters being doctors, have better connect with doctors

Advanced and high-end medical equipment and technology

• Hospitals are equipped with machines and devices with sophisticated technology •

Strive to introduce cutting-edge medical technology and state-of-the-art equipment

• Catheterization Laboratory • Computerized Tomography Scan

Diagnostic Equipment

Certifications

(CT Scan)

• Magnetic Resonance Imaging (MRI) • State of the art imaging equipment - Mammography, Advanced EEG, Nerve conduction velocity, advanced surgical equipment etc.

• •

All hospitals are NABH accredited Received NABL certification for Noida Extension hospital, and Greater Noida hospital

• Well-equipped modular and other operation theatres with three stage air filtration and laminar flow • Operating microscopes, image intensifiers, and laparoscopic equipment

Operation Theatres

• Critical care units are equipped

•

with high-end patient monitoring devices, ventilators and dedicated isolation rooms Facilities for haemodialysis, sustained low-efficiency dialysis, endoscopy and bronchoscopy are available 24x7 by the bedside

Critical care Equipment

Team of highly qualified medical professionals

Highly qualified and certified medical professionals and other staff

Number of Doctors (March’23)

Full Time Employees (March’23)

Visiting, 164

Consultant , 267

Resident Medical, 178

Corporate and Support

Staff, 1516

Nurses, 799

Resident Medical Doctors, 178

Paramedical, 379

Accolades received by our doctors

Initiatives to improves talent pool

GRIMPER Best Publication Award, 2012 Dr. Neeraj Chaudhary

Delhi Ratan Award, 2011 Dr. Girish Chander Vaishnava

Continuously training doctors, nurses and paramedical staff

Keep staff abreast with global developments concerning the health sector

Provide better doctor visibility amongst the potential patients through marketing and awareness campaigns

Experienced and professional management team

Leadership Promoted by experienced medical professionals, Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar

Management Led by experienced and qualified professional management team

Brand Strong brand equity led by ✓ First mover advantage in regional

territories

✓ One of the best healthcare infra ✓ Personalized connect with patients

Dr. Ajay Kumar Tyagi Chairman & Whole-time Director

Dr. Kapil Kumar Managing Director

Yatharth Tyagi Whole-time Director

Amit Kumar Singh Chief Executive Officer

Deepak Kumar Tyagi President, Strategy and Finance

Pankaj Prabhakar Chief Financial Officer

Track record of stable operating and financial performance

1. Stable operating &

financial performance

2. Continued growth over the past

three fiscals

Growth led by strong operational efficiency: 1.

Streamlining clinical and administrative functions

2. Continually introducing process

innovations

3. Maintaining economies of scale

Optimizing Capex Allocation 1. Reinvesting in increasing bed

capacity and opening new hospitals Incurring lower capital expenditure per operational bed

3. Making optimal use of the available area in our hospitals and working better with equipment suppliers

FY21-23 CAGR Revenue: 51% EBITDA: 41%

2287

670

n m s R

5203

4009

1,108

1,338

) e u n e v e r

f o % ( 3 2 Y F

27%

18%

17%

26%

21%

8,0 00.00

7,0 00.00

6,0 00.00

5,0 00.00

4,0 00.00

3,0 00.00

2,0 00.00

1,0 00.00

0.0 0

n m s R

FY21

FY22

Revenue

FY23

EBITDA

Material and

Employee Cost

EBITDA Margin

Consumables

Yatharth

Peer Average

3.91

3.72

3.07

9 1 3 4

4.0 0

3.0 0

2.0 0

1.0 0

0.0 0

4 7 3 3

FY21

0 9 0 4

FY22

FY23

Gross Capex

Capex per Operational Bed

Growth Strategy

Continue to improve our quality of care and operational efficiencies

Introduce new specialties at existing hospitals

Grow medical tourism segment to attract international patients

Further leverage technology to grow operations

Augment scale through organic and inorganic manner in current markets and expand into adjacent regions

Key Growth Drivers (1/2)

Improving specialty mix towards high value specialties

Introduce new specialties at existing hospitals

Grow medical tourism segment to attract international patients

➢ Increase in share of higher value such as Neurology, Nephrology, Oncology,

specialties Cardiology, Orthopedics resulting to higher ARPOB

and

➢ Further

super- strengthening specialties by on-boarding new reputable and experienced doctors

➢ Incremental

organ share transplant in Greater Noida & Noida Extension to enhance mix of high value specialties

➢ Noida Extension taking the lead by offering radiation line for oncology treatments

➢ Close proximity to the upcoming Asia’s largest airport at Greater Noida

➢ Kidney Transplant already started at Noida Extension & Greater Noida, and liver transplant to start soon

➢ Focus on orthopedics,

cardiac sciences, gastrointestinal surgery international for and patients

urology

➢ Align marketing strategies to target

medical tourists

➢ Started soft marketing of radiation

line

Key Growth Drivers (2/2)

Targeting Balanced Growth

Leverage technology to grow operations

Improving utilization & Jhansi hospital stabilization

➢ Augment scale through organic and inorganic manner in current markets and expand into adjacent regions

➢ Expand in Tier II cities of Northern

➢ Adopt

the

latest

medical technologies and equipment to improve the quality of care and of success augment surgeries

rates

India

➢ Plan to introduce robotic surgeries

➢ Acquired adjacent land parcels in Greater Noida & exploring further opportunities to support expansion of Noida Extension hospital

➢ Focus towards increasing ARPOB and better management of ALOS in Noida, Greater Noida & Noida Extension

➢ Jhansi operations began in FY23, with a utilization of 8%. With stabilization of Jhansi hospital, ARPOB & utilization to improve in the coming quarters

Growth Opportunity

Delhi NCR region

Jhansi-Orchha- Gwalior

Delhi-NCR attracts patients from adjoining states with inadequate healthcare facilities

➢ Noida, Greater Noida and Noida extension attract patients from the

NCR region, other nearby states and even internationally

➢ Even with high bed densities, hospitals in the region have shown high occupancy rates indicating potential for further growth and expansion

➢ Opportunity to expand in other tier II cities of Northern India

Particulars

Delhi-NCR

Noida

Greater Noida

Noida Extension

Ghaziabad

Jhansi- Orchha- Gwalior

Population - 2021

~70 million

~0.8 million

~0.4 million ~6.5 million

~3.7 million

# Hospital beds

~163,000

~4,300

~2,500

~1,000

~7,200

~7,900

# Hospitals

~2,150

~175

~30

~15-20

~280

~215

% hospitals belonging to large chains

~2-3%

~10%

~5-10%

~2-3%

Source: CRISIL

Appendix

Awards and Accreditations

2020

2021

2023

➢ Awarded 1st in Swachhta Ranking

➢ Covid Thank You award by Niva

➢ Awarded UP Ratan Samman by

(for quarter ended Sep 2019) in

Bupa

Dainik Jagran Inext

Swachh Survekshan League 2020 by

➢ 5-star

grading

Infomerics

➢ Accreditation (ISO 15189:2012) from

Noida Authority

Analysts & Research for our hospitals

NABL for medical testing to the Noida

➢ Recognized as Emerging Hospital

located at Noida, Noida Extension &

Extension Hospital,

Chain in Delhi NCR by Medico Trip

Greater Noida

➢ Accreditation from NABH to the

India

➢ Accreditation from NABH to the

Jhansi-Orchha Hospital

➢ Accreditation (ISO 15189:2012) from

Noida Extension Hospital

NABL for molecular testing (RTPCR-

Covid 19) for the Noida Extension

Hospital

Board of Directors (1/2)

Dr. Ajay Kumar Tyagi Chairman & Whole-time Director

Dr. Kapil Kumar Managing Director

Yatharth Tyagi Whole-time Director

➢ Over 17 years of experience in medical

➢ Over 17 years of experience in medicine

➢ Associated with the company since 2019

care and hospital management

and healthcare

➢ Associated with the Company since its

incorporation

➢ Previously associated with Medical Health Family Welfare U.P. L.K.O

➢ Holds a degree of bachelor of medicine, bachelor of surgery, and diploma in orthopaedics

➢ Previously associated with Lady Hardinge Medical College, Smt. Sucheta Kriplani Hospital and Noida Orthopedic Hospital

➢ Holds a degree of bachelor of medicine,

bachelor of surgery, and master of surgery in orthopedic surgery. Also completed magister chirurgie in orthopedics

➢ Holds a bachelor’s degree in business and management from Leeds Beckett University, United Kingdom and holds a master of science degree in International Health Management from Imperial College, London

➢ Responsible for overall operations and business development for the company

Board of Directors (2/2)

Promila Bhardwaj Independent Director

Mukesh Sharma Independent Director

Sanjeev Upadhyaya Independent Director

➢ Over 35 years of experience in public

➢ Over 35 years of experience in banking

➢ Over 20 years of experience in

administration

➢ Previously associated with Bank of

community medicines

➢ Joined Indian revenue services in the

Baroda

year 1979, and retired as DGIT (Systems) from Directorate of Income Tax (systems)

➢ Holds a degree of bachelor of arts and master’s of arts in English, master of philosophy in social sciences, and master’s diploma in public administration

➢ Holds a bachelor’s degree in science

agriculture & animal husbandry, master’s degree in business administration and post graduate diploma in labour law, labour welfare and personnel management, also holds a degree of bachelor’s of law

➢ Previously associated with E.S.I. Hospital, Aga Khan Foundation Project, United Nations’ Children’s Fund and other organizations

➢ Holds a bachelor’s degree in medicine and bachelor of surgery, and doctor of medicine in community medicine

Management Team

Amit Kumar Singh Chief Executive Officer

Pankaj Prabhakar Chief Financial Officer

Deepak Kumar Tyagi President, Strategy and Finance

➢ Over 17 years of experience in hospital

management

➢ Over 16 years of experience incorporate finance of several healthcare institutions

➢ Approximately 14 years of experience

incorporate finance

➢ Previously associated with Centre for

➢ Previously associated with Rockland

Sight, Raksha Medicare Private Limited, Veeda Clinical Research Private Limited, Indira Gandhi Eye Hospitals, Radiant Life Care Private Limited

➢ Holds bachelor’s degree in art,

postgraduate diploma in Hospital and Health Management

Hospital, Max Devki Devi Heart & Vascular Institute, Fortis Flt. L.T. Rajan Dhall Hospital, Artemis Medicare Services Private Limited, Max Healthcare Institute Limited and Asian Institute of Medical Sciences

➢ Holds a bachelor’s degree and is an associate member of the Institute of Chartered Accountants of India

➢ Previously associated with Prometric Testing Private Limited and Mind Shapers Technologies Private Limited

➢ Holds a Bachelor’s degree in commerce and completed course of study in French from University of Delhi

➢ Associate member of the Institute of

Company Secretaries of India and the Institute of Chartered Accountants of India

Shareholding Pattern

Shareholding Pattern*

20.34%

4.25%

9.07%

BSE Ticker

543950

NSE Ticker

YATHARTH

66.33%

Market Capitalization*

Rs. 28,653 mn

No. of shares outstanding

8,58,50,233

Promoter Group

DIIs

FIIs

Others

* As on listing date – Aug 7, 2023; Shareholding pattern is as on IPO allotment date

Thank You

Yatharth Hospital & Trauma Care Services Ltd

CIN: L85110DL2008PLC174706

www.yatharthhospitals.com

Investor Relations

investor.relations@yatharthhospitals.com

m o c

a t

p s o h h t

r a h t a y

w w w

← All Transcripts YATHARTH Stock Page →

Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Investor Presentation

Market Movers